Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/03/2002WO2002076983A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002WO2002076982A2 Non-nucleoside reverse transcriptase inhibitors
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076975A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002WO2002076973A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
10/03/2002WO2002076971A1 Compounds useful for inhibiting paramyxovirus neuraminidase
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076941A2 Histone deacetylase inhibitors
10/03/2002WO2002076935A1 Novel a-lipoic acid derivative and use thereof
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076548A2 Methods and apparatus for treating diseased tissue
10/03/2002WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002WO2002076505A1 Remedies for post-traumatic stress disorder
10/03/2002WO2002076504A1 Remedies for inflammatory bowel diseases
10/03/2002WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
10/03/2002WO2002076499A2 Combination treatment of pancreatic cancer
10/03/2002WO2002076497A2 Method and composition
10/03/2002WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
10/03/2002WO2002076491A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076484A2 Combination of a taxane and a cyclin-dependent kinase inhibitor
10/03/2002WO2002076482A2 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
10/03/2002WO2002076481A1 Composition and method of use in treating sexual dysfunction using cgmp-specific phosphodiesterase type 5 inhibitors
10/03/2002WO2002076479A1 Composition for treating acne vulgaris and fabrication method
10/03/2002WO2002076478A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076475A2 Glycosaminoglycan anticoagulants derived from fish
10/03/2002WO2002076474A1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
10/03/2002WO2002076473A1 Quercetin derivative and its medicinal use
10/03/2002WO2002076472A2 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
10/03/2002WO2002076471A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
10/03/2002WO2002076470A1 External skin compositions
10/03/2002WO2002076467A1 Compositions and methods to regulate bone and mineral metabolism
10/03/2002WO2002076465A1 Oestrogen and fatty acid monoester as a hypolipidaemic and antidiabetic agent
10/03/2002WO2002076464A1 Anti-psychosis combination
10/03/2002WO2002076463A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076462A1 Drugs for improving insulin resistance
10/03/2002WO2002076461A1 Combination of reboxetine and citalopram
10/03/2002WO2002076460A2 Use of propentofylline to control intraocular pressure
10/03/2002WO2002076459A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002WO2002076458A1 Antimicrobial drug reduced in effect on heart
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076456A1 Method for inhibiting apoptosis of stem cells
10/03/2002WO2002076455A1 Autonomic controlling agents and health drinks and foods
10/03/2002WO2002076454A1 Method for treatment of cancer and compositions for use therein
10/03/2002WO2002076452A1 Use of melationin in the manufacture of a medicament for treating attention deficit hyperactive disorder
10/03/2002WO2002076451A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076449A1 Treatment of rosacea using lipoic acid
10/03/2002WO2002076448A1 Molecular conjugates for use in treatment of cancer
10/03/2002WO2002076446A1 Esmolol formulation
10/03/2002WO2002076445A1 Agents against stress-induced diseases drugs
10/03/2002WO2002076444A1 Molecular neurochirurgerie for pain control administering locally capsaicin or resiniferatoxin
10/03/2002WO2002076443A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/03/2002WO2002076442A1 Stable aqueous liquid preparation
10/03/2002WO2002076441A1 Microemulsions as precursors to solid nanoparticles
10/03/2002WO2002076440A2 Methods of treating alzheimer's disease with piperidin derivates
10/03/2002WO2002076439A2 Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076437A2 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002WO2002076435A2 Lipid profile modulation with steroids
10/03/2002WO2002076434A2 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/03/2002WO2002076433A1 Dental formulation
10/03/2002WO2002076432A2 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
10/03/2002WO2002076426A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/03/2002WO2002076423A2 Skin care compositions containing a sugar amine
10/03/2002WO2002076409A2 Cosmetic and dermatological preparations comprising an isoflavone content
10/03/2002WO2002076405A2 Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076401A2 Method of attenuating reactions to skin irritants
10/03/2002WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/03/2002WO2002076398A2 Improved forms of pharmaceutically active agents and method for manufacture thereof
10/03/2002WO2002076397A2 Telomerase inhibitors and methods of their use
10/03/2002WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002WO2002076393A2 Antiagionecic, antitumor, chemopreventative agents
10/03/2002WO2002076390A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
10/03/2002WO2002076388A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002WO2002076381A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
10/03/2002WO2002076376A2 A stable pharmaceutical composition of pravastatin
10/03/2002WO2002076375A2 Process for the preparation of benazepril
10/03/2002WO2002076242A1 Nutritional supplement to treat macular degeneration
10/03/2002WO2002076241A1 Preparation for the prevention and/or treatment of altered bone metabolism
10/03/2002WO2002076234A2 Increasing phosphorus uptake from the gut of dairy cows by supplementing with 1-alpha-hydroxylated vitamin d
10/03/2002WO2002076229A1 One-step process for preparing chewing gum
1 ... 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 5704 5705 5706 5707 5708 5709 ... 7860